30 Oct 2025 | 5 Mins Read
Dr Reddy's stock drops 5%, should investors act?
Flipitmoney
Dr Reddy's Laboratories share price fell 5.6% to Rs 1,180.90 on the National Stock Exchange after receiving a Notice of Non-Compliance (NON) from the Pharmaceutical Drugs Directorate, Canada, for its Abbreviated New Drug Submission (ANDS) for Semaglutide Injection. The company will respond within the stipulated time period and remains committed to making the therapy available.